Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;33(8):1448-1458.
doi: 10.1681/ASN.2022010036. Epub 2022 Apr 8.

High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity

Affiliations
Review

High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity

Candice Z Ulmer et al. J Am Soc Nephrol. 2022 Aug.

Abstract

Full-length parathyroid hormone (PTH 1-84) is crucial for the regulation of calcium and phosphate homeostasis and bone remodeling. PTH 1-84 is metabolized into various PTH fragments, which are measured with varying levels of efficiency by PTH immunoassays. These PTH fragments, which increase in serum as CKD progresses, could potentially modulate the effects of PTH 1-84 and contribute to CKD-associated bone disorders. To obtain a true biologic representation of total PTH bioactivity, it is necessary to measure not only PTH 1-84 but also PTH fragments that are present in circulation. Traditional second-generation PTH immunoassays collectively measure PTH 1-84, PTH fragments, and post-translationally modified PTH 1-84, making it difficult to accurately predict the character of underlying renal osteodystrophy. This review highlights current advances in methods available for PTH measurement and the clinical relevance of PTH fragments in CKD. We emphasize the usefulness of mass spectrometry as a potential reference method for PTH measurement.

Keywords: mass spectrometry; mineral metabolism; parathyroid hormone.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Long-standing CKD and ESKD are associated with metabolic disturbances that lead to hypersecretion of PTH and FGF23, hyperphosphatemia, calcitriol deficiency and resistance, and hypocalcemia. Common complications of secondary hyperparathyroidism include bone diseases and cardiovascular calcifications that may contribute to cardiovascular mortality. CaSR, calcium-sensing receptor; EPO, erythropoietin; FGF23, fibroblast growth factor 23; FGFR1, fibroblast growth factor receptor 1; RAAS, renin-angiotensin-aldosterone system; VDR, vitamin D receptor.
Figure 2.
Figure 2.
Serum concentrations of PTH 1–84 and PTH fragments increased as kidney function declined, and increased significantly when the eGFR decreased to ≤17–23 ml/min per 1.73 m2. Reprinted from ref. , with permission.

Similar articles

Cited by

References

    1. Kritmetapak K, Losbanos LA, Hines JM, O’Grady KL, Ulmer CZ, Vesper HW, et al. : Chemical characterization and quantification of circulating intact PTH and PTH fragments by high-resolution mass spectrometry in chronic renal failure. Clin Chem 67: 843–853, 2021 - PMC - PubMed
    1. Zhang CX, Weber BV, Thammavong J, Grover TA, Wells DS: Identification of carboxyl-terminal peptide fragments of parathyroid hormone in human plasma at low-picomolar levels by mass spectrometry. Anal Chem 78: 1636–1643, 2006 - PubMed
    1. Lopez MF, Rezai T, Sarracino DA, Prakash A, Krastins B, Athanas M, et al. : Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clin Chem 56: 281–290, 2010 - PubMed
    1. Ketha H, Singh RJ: Quantitation of parathyroid hormone in serum or plasma by liquid chromatography-tandem mass spectrometry. Methods Mol Biol 1378: 211–217, 2016 - PubMed
    1. Evenepoel P, Bover J, Ureña Torres P: Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90: 1184–1190, 2016 - PubMed

Publication types